Jitsubo Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 15


  • Latest Deal Type
  • M&A

Jitsubo General Information


Developer of peptide generic products intended to contribute to the well-being of society through innovative peptide therapeutics. The company offers services related to peptide pharmaceuticals, contract manufacturing of peptide APIs and licensing regarding active ingredient manufacturing technology for peptides, enabling the patient to get peptide pharmaceuticals at a low and affordable cost.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Parent Company
Corporate Office
  • 4-1 Life Science Research Center, 1-1-43 Suehiro-cho
  • Tsurumi-ku, Yokohama-shi
  • Kanagawa, 230-0045
  • Japan
+81 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jitsubo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 30-Apr-2021 Completed Generating Revenue
2. Later Stage VC 11-Nov-2016 Completed Generating Revenue
1. Merger/Acquisition 26-Dec-2014 $3.61M 00.000 Completed Generating Revenue
To view Jitsubo’s complete valuation and funding history, request access »

Jitsubo Patents

Jitsubo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11420997-B2 Peptide synthesis method Active 13-Apr-2018 00000000 00
US-20210139532-A1 Peptide synthesis method Active 13-Apr-2018 000000000
EP-3778621-A1 Peptide synthesis method Active 13-Apr-2018 00000000
EP-3778621-A4 Peptide synthesis method Active 13-Apr-2018 00000000 0
JP-6703668-B2 Peptide synthesis method Active 13-Apr-2018 C07K1/042
To view Jitsubo’s complete patent history, request access »

Jitsubo Executive Team (7)

Name Title Board Seat
Hideya Mizufune Ph.D Chief Executive Officer
Kazuaki Kanai Ph.D Chief Executive Officer
Kiichiro Ohya Executive Vice President & Chief Strategy Officer
Kazuhiro Chiba Ph.D Founder
You’re viewing 4 of 7 executive team members. Get the full list »

Jitsubo Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Jitsubo Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Nxera Pharma Corporation Majority 000 0000 000000 0
Universal Materials Incubator Venture Capital Minority 000 0000 000000 0
WiL (World Innovation Lab) Venture Capital Minority 000 0000 000000 0
To view Jitsubo’s complete investors history, request access »

Jitsubo FAQs

  • When was Jitsubo founded?

    Jitsubo was founded in 2005.

  • Who is the founder of Jitsubo?

    Kazuhiro Chiba Ph.D is the founder of Jitsubo.

  • Who is the CEO of Jitsubo?

    Hideya Mizufune Ph.D and Kazuaki Kanai Ph.D are the CEOs of Jitsubo.

  • Where is Jitsubo headquartered?

    Jitsubo is headquartered in Kanagawa, Japan.

  • What is the size of Jitsubo?

    Jitsubo has 15 total employees.

  • What industry is Jitsubo in?

    Jitsubo’s primary industry is Biotechnology.

  • Is Jitsubo a private or public company?

    Jitsubo is a Private company.

  • What is Jitsubo’s current revenue?

    The current revenue for Jitsubo is 00000.

  • Who are Jitsubo’s investors?

    Nxera Pharma, Universal Materials Incubator, and WiL (World Innovation Lab) have invested in Jitsubo.

  • When was Jitsubo acquired?

    Jitsubo was acquired on 30-Apr-2021.

  • Who acquired Jitsubo?

    Jitsubo was acquired by Astena Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »